POMC and systemic lupus erythematosus: This “ACTH renaissance” applies to conditions like multiple sclerosis [2, 37], proteinuric nephropathies [16], and lupus [24], where the anti-inflammatory properties of ACTH might also be mediated through the peripheral, or non-adrenal, MC system.